| Date Filed | Type | Description |
| 11/16/2021 |
4
| Pfeffer Cary (Director) has filed a Form 4 on Jounce Therapeutics, Inc. |
| 09/17/2021 |
4
| Pfeffer Cary (Director) has filed a Form 4 on Jounce Therapeutics, Inc. |
| 06/22/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/14/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/15/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/03/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/23/2020 |
4
| Pfeffer Cary (Director) has filed a Form 4 on Jounce Therapeutics, Inc. |
| 11/19/2020 |
4
| Pfeffer Cary (Director) has filed a Form 4 on Jounce Therapeutics, Inc. |
| 11/13/2020 |
4
| Pfeffer Cary (Director) has filed a Form 4 on Jounce Therapeutics, Inc. |
| 07/02/2020 |
4/A
| Pfeffer Cary (Director) has filed a Form 4 on Jounce Therapeutics, Inc.|
Txns:
| Granted 15,700 options to buy
@ $7.58, valued at
$119k
|
|
| 06/29/2020 |
4
| Pfeffer Cary (Director) has filed a Form 4 on Jounce Therapeutics, Inc.|
Txns:
| Granted 13,550 options to buy
@ $7.58, valued at
$102.7k
|
|
| 05/06/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/27/2019 |
4
| Pfeffer Cary (Director) has filed a Form 4 on Neon Therapeutics, Inc.|
Txns:
| Granted 18,500 options to buy
@ $4.64, valued at
$85.8k
|
|
| 06/13/2019 |
4
| Pfeffer Cary (Director) has filed a Form 4 on Jounce Therapeutics, Inc.|
Txns:
| Granted 15,700 options to buy
@ $4.46, valued at
$70k
|
|
| 07/03/2018 |
4
| Pfeffer Cary (Director) has filed a Form 4 on Neon Therapeutics, Inc.|
Txns:
| Converted preferred shares
@ $0 |
|
| 06/26/2018 |
3
| Pfeffer Cary (Director) has filed a Form 3 on Neon Therapeutics, Inc. |
| 06/21/2018 |
4
| Pfeffer Cary (Director) has filed a Form 4 on Jounce Therapeutics, Inc.|
Txns:
| Granted 13,550 options to buy
@ $7.92, valued at
$107.3k
|
|
| 02/03/2017 |
4
| Pfeffer Cary (Director) has filed a Form 4 on Jounce Therapeutics, Inc.|
Txns:
| Converted preferred shares
@ $0
Converted preferred shares
@ $0 |
|
| 01/26/2017 |
3
| Pfeffer Cary (Director) has filed a Form 3 on Jounce Therapeutics, Inc. |
| 06/10/2016 |
4
| Pfeffer Cary (Director) has filed a Form 4 on Eleven Biotherapeutics, Inc.|
Txns:
| Granted 8,072 options
@ $1.83, valued at
$14.8k
|
|